Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats

被引:10
作者
Antus, B
Liu, SY
Yao, YS
Zou, HQ
Song, EW
Lutz, J
Heemann, U
机构
[1] Semmelweis Univ, Dept Pathophysiol, H-1089 Budapest, Hungary
[2] Klinikum Rechts Der Isar, Dept Nephrol, D-81576 Munich, Germany
基金
匈牙利科学研究基金会;
关键词
chronic allograft nephropathy; growth factor; oestradiol; progesterone;
D O I
10.1093/ndt/gfh602
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 [基础医学]; 1002 [临床医学]; 100602 [中西医结合临床];
摘要
Background. We recently demonstrated that oestrogeris ameliorate the progression of chronic allograft nephropathy (CAN). In our present study, we investigated the role of progesterone and selective oestrogen receptor modulators (SERMs) in this process. Methods. Female Fisher (F344) kidneys were orthotopically transplanted into intact or ovariectomized female Lewis recipients. Ovariectomized recipients were divided into Four groups and were treated with either progesterone alone or in combination with oestradiol. oestradiol alone or vehicle. Intact recipients were divided into three groups and were treated with SERMs Such as tamoxifen and one of its new derivatives. droloxifene or vehicle. Animals were harvested 24 weeks after transplantation for histological and immunohistological Studies as well as for Molecular analysis. Results. Administration of progesterone resulted In increased urinary protein excretion as well as profound glomerulosclerosis and mononuclear cell infiltration. The combined treatment had similar detrimental effects on the development of CAN. In contrast, oestradiol treatment alone improved graft function, reduced (glomerulosclerosis and diminished cellular infiltration. SERMs again impaired allograft function and promoted the development of CAN. Renal allograft damage paralleled intragraft mRNA expression of transforming growth factor-beta1 in all groups. Conclusions. Our results suggest that addition of progesterone diminishes the beneficial effects of oestrogens on the development of CAN in rats. Similarly to progesterone. SERMs worsened long-term renal allograft Outcome.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 22 条
[1]
Estradiol is nephroprotective in the rat remnant kidney [J].
Antus, B ;
Hamar, P ;
Kokeny, G ;
Szollosi, Z ;
Mucsi, I ;
Nemes, Z ;
Rosivall, L .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (01) :54-61
[2]
Opposite effects of testosterone and estrogens on chronic allograft nephropathy [J].
Antus, B ;
Yao, YS ;
Song, EW ;
Liu, SY ;
Lutz, J ;
Heemann, U .
TRANSPLANT INTERNATIONAL, 2002, 15 (9-10) :494-501
[3]
ANDROGENIC, ANTI-ANDROGENIC, AND SYNANDROGENIC ACTIONS OF PROGESTINS - ROLE OF STERIC AND ALLOSTERIC INTERACTIONS WITH ANDROGEN RECEPTORS [J].
BULLOCK, LP ;
BARDIN, CW ;
SHERMAN, MR .
ENDOCRINOLOGY, 1978, 103 (05) :1768-1782
[4]
Effects of partial versus pure antiestrogens on ovulation and the pituitary-ovarian axis in the rat [J].
Donath, J ;
Nishino, Y .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 66 (04) :247-254
[5]
EPPENBERGER U, 1991, AM J CLIN ONCOL S2, V14, P5
[6]
INFLUENCE OF DROLOXIFENE (3-HYDROXYTAMOXIFEN), 40 MG DAILY, ON PLASMA GONADOTROPINS, SEX-HORMONE BINDING GLOBULIN AND ESTROGEN-LEVELS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS [J].
GEISLER, J ;
EKSE, D ;
HOSCH, S ;
LONNING, PE .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (02) :193-195
[7]
Tamoxifen: Teaching an old drug new tricks? [J].
Grainger, DJ ;
Metcalfe, JC .
NATURE MEDICINE, 1996, 2 (04) :381-385
[8]
The pathobiology of chronic allograft nephropathy: Immune-mediated damage and accelerated aging [J].
Joosten, SA ;
van Kooten, C ;
Sijpkens, YWJ ;
de Fijter, JW ;
Paul, LC .
KIDNEY INTERNATIONAL, 2004, 65 (05) :1556-1559
[9]
DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS IN OVARIECTOMIZED RATS [J].
KE, HZ ;
SIMMONS, HA ;
PIRIE, CM ;
CRAWFORD, DT ;
THOMPSON, DD .
ENDOCRINOLOGY, 1995, 136 (06) :2435-2441
[10]
Effects of sex hormones on mesangial cell proliferation and collagen synthesis [J].
Kwan, G ;
Neugarten, J ;
Sherman, M ;
Ding, Q ;
Fotadar, U ;
Lei, J ;
Silbiger, S .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1173-1179